{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T23:31:37Z","timestamp":1768692697676,"version":"3.49.0"},"reference-count":17,"publisher":"Massachusetts Medical Society","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2024,10,17]]},"DOI":"10.1056\/nejmc2411003","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T21:04:36Z","timestamp":1729112676000},"page":"1461-1463","source":"Crossref","is-referenced-by-count":3,"title":["Two Trials of Therapeutics for MASH with Liver Fibrosis"],"prefix":"10.1056","volume":"391","member":"150","reference":[{"key":"e_1_2_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2401943"},{"key":"e_1_2_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2401755"},{"key":"e_1_2_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.10.017"},{"key":"e_1_2_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2018.11.014"},{"key":"e_1_3_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.039"},{"key":"e_1_3_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-021-00519-y"},{"key":"e_1_3_3_2_4_2","first-page":"691","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications.","volume":"73","author":"Targher G","year":"2024","unstructured":"Targher G, Byrne CD, Tilg H. MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut 2024;73:691-702.38228377","journal-title":"Gut"},{"key":"e_1_3_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2024.04.016"},{"key":"e_1_4_3_2_2_2","first-page":"76","article-title":"Prognostic relevance of metabolic dysfunction-associated steatohepatitis for patients with chronic hepatitis B.","volume":"11","author":"Rugivarodom M","year":"2023","unstructured":"Rugivarodom M, Pongpaibul A, Chainuvati S, et al. Prognostic relevance of metabolic dysfunction-associated steatohepatitis for patients with chronic hepatitis B. J Clin Transl Hepatol 2023;11:76-87.36406326","journal-title":"J Clin Transl Hepatol"},{"key":"e_1_4_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-14-0614"},{"key":"e_1_5_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03172-7"},{"key":"e_1_5_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01707-4"},{"key":"e_1_5_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(22)00243-1"},{"key":"e_1_5_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2023.09.007"},{"key":"e_1_5_3_2_6_2","unstructured":"A study of tirzepatide (LY3298176) on the reduction on morbidity and mortality in adults with obesity (SURMOUNT-MMO). ClinicalTrials.gov 2024 (https:\/\/clinicaltrials.gov\/study\/NCT05556512)."},{"key":"e_1_6_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2017.13"},{"key":"e_1_6_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.06.003"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMc2411003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T22:36:02Z","timestamp":1749681362000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMc2411003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,17]]},"references-count":17,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2024,10,17]]}},"alternative-id":["10.1056\/NEJMc2411003"],"URL":"https:\/\/doi.org\/10.1056\/nejmc2411003","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,17]]}}}